Connect your AI

SRTA SRTA Debt Issuance Costs

Debt Issuance Costs at other companies

GXO LogisticsGXO

$500K-77.8%

Astrana HealthASTH

$0-100%

Kestra Medical Technologies, Ltd. Common StockKMTS

$588.25K—

HaemoneticsHAE

$0—

RXORXO

$8M—

Other financials

Income statement

Revenue$67.4M+87.4%

Gross profit$14.1M+100%

Operating income-$3.0M+47.7%

Net income$2.2M+162%

EPS (diluted)$0.03+175%

Balance sheet

Cash & equivalents$59.0M+65.3%

Total debt$4.5M-50.7%

Total equity$285.7M+30.0%

Total assets$327.6M+30.8%

Cash flow

Operating cash flow$3.9M+1,679%

CapEx$5.2M+98.1%

Free cash flow-$1.3M+54.8%

Valuation

Market cap$463.78M+24.0%

Enterprise value$409.26M—

P/E8.9×—

P/S1.8×—

Profitability

Gross margin21.7%+1.3pp

Operating margin-7.8%-2.8pp

Net margin21%+13.6pp

FCF margin-22.4%+1,712pp

Returns & leverage

Return on equity15.6%+10.0pp

Debt / equity0×0.0×

Current ratio5.9×-1.0×

Where this comes from

Reported directly by SRTA in its filing.

Tagged under the XBRL concept us-gaap:PaymentsOfDebtIssuanceCosts.

The official record: SRTA’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about SRTA's debt issuance costs.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is SRTA's debt issuance costs?: SRTA (SRTA) reported debt issuance costs of $329K in Q1 2026.
What does debt issuance costs mean?: Cash paid for fees, legal costs, and underwriting discounts associated with issuing new debt.